Repligen (NASDAQ:RGEN) Coverage Initiated at TD Cowen
Equities research analysts at TD Cowen initiated coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a note issued to investors on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $200.00 price target on the biotechnology company’s stock. TD Cowen’s price target points to a potential upside of 33.79% […]
Equities research analysts at TD Cowen initiated coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a note issued to investors on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $200.00 price target on the biotechnology company’s stock. TD Cowen’s price target points to a potential upside of 33.79% […]
